Shopping Cart
- Remove All
- Your shopping cart is currently empty
KP-457 is a specific inhibitor of a disintegrin-metalloproteinase 17 (ADAM17) and a TNFα converting enzyme TACE inhibitor that blocks the production of soluble TNF (sTNF).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $93 | In Stock | |
5 mg | $228 | In Stock | |
10 mg | $372 | In Stock | |
25 mg | $689 | In Stock | |
50 mg | $1,090 | In Stock | |
100 mg | $1,480 | In Stock | |
1 mL x 10 mM (in DMSO) | $243 | In Stock |
Description | KP-457 is a specific inhibitor of a disintegrin-metalloproteinase 17 (ADAM17) and a TNFα converting enzyme TACE inhibitor that blocks the production of soluble TNF (sTNF). |
Targets&IC50 | MMP2:0.717 μM, ADAM10:0.748 μM, MMP9:5.41 μM, MMP17:7.1 μM, MMP8:2.2 μM, MMP13:0.93 μM, ADAM17:0.111 μM, MMP14:2.14 μM, MMP3:9.760 μM |
In vitro | b>METHODS: The ability of KP-457 (15 μM) to inhibit GPIbα shedding during in vitro generation of iPSC platelets was studied when administered during the MK differentiation and thrombopoietic stages of HPC cultured at 37°C. RESULTS: KP-457 had no significant effect on MK numbers; retention of GPIbα by KP-457 was consistently observed in platelets derived from human embryonic stem cells and imMKCLs. [1] KP-457 is a selective metalloproteinase 17 (ADAM17) inhibitor, with selectivity for ADAM17 over other MMPs and ADAM10, with IC50 values of 0.011 μM (ADAM17), 0.748 μM (ADAM10), 0.717 μM (MMP2), 9.760 μM (MMP3), 2.2 μM (MMP8), 5.41 μM (MMP9), 0.93 μM (MMP13), 2.140 μM (MMP14), and 7.1 μM (MMP17), respectively. [1] |
Alias | KP457, KP 457 |
Molecular Weight | 480.56 |
Formula | C21H24N2O7S2 |
Cas No. | 1365803-52-6 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (208.09 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.